EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieKlinische Studie (Phase I)Open Access · CC BY-NC 3.0

Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Food Effects of Single and Multiple Oral Doses of ABP-671 in Healthy and Hyperuricemic Subjects

Marc Gurwith, Roy J Wu, Ullrich Schwertschlag, Adam W Jin, Dongfang Shi

Drug Design, Development and Therapy · 2025-11 · Volume 19 · 10607-10620

DOI: 10.2147/dddt.s553918 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Drug Design, Development and Therapy, 2025-11. Verfasst von Marc Gurwith und 4 weiteren Autor:innen. Beteiligte Einrichtung: Atom Therapeutics Co., Ltd, Hangzhou, Zhejiang, 310018, People's Republic of China. Hauptthemen laut MEDLINE: Food-Drug Interactions, Hyperuricemia. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Food-Drug InteractionsHyperuricemiaHumansAdministration, OralMaleAdultFemaleCross-Over StudiesMiddle AgedDose-Response Relationship, DrugHealthy VolunteersYoung AdultDouble-Blind MethodUric Acid

Stichwörter der Autor:innen

ABP-671food effecthyperuricemiapharmacodynamicspharmacokineticssafetyserum uric acid

Substanzen

Uric Acid

Autor:innen und Institutionen

  • Atom Therapeutics Co., Ltd, Hangzhou, Zhejiang, 310018, People's Republic of China.

Zitieren

APA

Gurwith, M., Wu, R. J., Schwertschlag, U., Jin, A. W., & Shi, D. (2025). Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Food Effects of Single and Multiple Oral Doses of ABP-671 in Healthy and Hyperuricemic Subjects. Drug Design, Development and Therapy, Volume 19, 10607-10620. https://doi.org/10.2147/dddt.s553918

Vancouver

Gurwith M, Wu RJ, Schwertschlag U, Jin AW, Shi D. Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Food Effects of Single and Multiple Oral Doses of ABP-671 in Healthy and Hyperuricemic Subjects. Drug Design, Development and Therapy. 2025;Volume 19:10607-10620. doi:10.2147/dddt.s553918

BibTeX
@article{Gurwith2025,
  author = {Gurwith, Marc and Wu, Roy J and Schwertschlag, Ullrich and Jin, Adam W and Shi, Dongfang},
  title = {Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Food Effects of Single and Multiple Oral Doses of ABP-671 in Healthy and Hyperuricemic Subjects},
  journal = {Drug Design, Development and Therapy},
  year = {2025},
  volume = {Volume 19},
  pages = {10607--10620},
  doi = {10.2147/dddt.s553918}
}
Kostenlos starten →